Craft
  • Home
  •  / iRhythm Technologies
iRhythm Technologies

iRhythm Technologies

Revenue

$322.8 M

FY, 2021

Market Capitalization

$4.5 B

2022-09-19

iRhythm Technologies Summary

Company summary

Overview
iRhythm Technologies is a digital healthcare company. It develops biosensing technology based on cloud-based data analytics and machine learning. The company offers Zio, a platform for early heart disease diagnostics.
Type
Public
Founded
2006
HQ
San Francisco, CA, US | view all locations
Website
http://www.irhythmtech.com/
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Michael J. Coyle

    Michael J. Coyle, President, Chief Executive Officer

    • Douglas Devine

      Douglas Devine, Chief Financial Officer

    • Allan Wilsker

      Allan Wilsker, Executive Vice President of Information Technology and Customer Service

    • Judy Lenane

      Judy Lenane, Executive Vice President, Products and Chief Clinical Officer

    LocationsView all

    5 locations detected

    • San Francisco, CA HQ

      United States

      699 8th St # 600, San Francisco

    • Cypress, CA

      United States

      11085 Knott Ave

    • Houston, TX

      United States

      5775 North Sam Houston Parkway West, Suite 200

    • Lincolnshire, IL

      United States

      2 Marriott Dr

    • London, England

      United Kingdom

      Seal House, 1 Swan Ln, Bridge

    iRhythm Technologies Financials

    Summary financials

    Revenue (Q2, 2022)
    $102.1M
    Gross profit (Q2, 2022)
    $70.2M
    Net income (Q2, 2022)
    ($23.9M)
    Cash (Q2, 2022)
    $101.3M
    EBIT (Q2, 2022)
    ($23.5M)
    Enterprise value
    $4.4B

    Footer menu